Cancerous disease modifying antibodies
Details for Australian Patent Application No. 2004205435 (hide)
International Classifications
Event Publications
8 September 2005 PCT application entered the National Phase
PCT publication WO2004/065422 Priority application(s): WO2004/065422
21 May 2009 Assignment before Grant
Arius Research, Inc. The application has been assigned to F.Hoffmann-La Roche AG
3 February 2011 Application Accepted
Published as AU-B-2004205435
2 June 2011 Standard Patent Sealed
16 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004205437-Pre-filled crystallization plates and methods for making and using same
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser